Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Neoplasm Metastasis 9 Stomach Neoplasms 5 Endometrial Neoplasms 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Adenocarcinoma 3 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Unresectable Locally Recurrent Breast Cancer 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Testicular Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neoplasms 1 Neoplasm, Residual 1 Mouth Neoplasms 1 Melanoma 1

Interventions

Letrozole 4 Fulvestrant 3 Anastrozole 2 AZD9833 2 trastuzumab deruxtecan 1 toripalimab 1 ribociclib 1 palbociclib 1 exemestane 1 elacestrant 1 disitamab vedotin 1 abemaciclib 1 Ritonavir 1 Paclitaxel 1 Lead 1 Itraconazole 1 Injections 1 Goserelin 1 AZD5305 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × trastuzumab deruxtecan × 30 days × Clear all

NCT06486883 2026-06-02

PONTIAC

MedSIR

Phase 2 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡